In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.74 in the prior trading day, Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $0.70, down -5.42%. In other words, the price has decreased by -$5.42 from its previous closing price. On the day, 0.67 million shares were traded. KPTI stock price reached its highest trading level at $0.75 during the session, while it also had its lowest trading level at $0.689.
Ratios:
Our goal is to gain a better understanding of KPTI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.56 and its Current Ratio is at 3.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 04 ’24 when Mano Michael sold 3,971 shares for $0.72 per share. The transaction valued at 2,866 led to the insider holds 273,881 shares of the business.
Paulson Richard A. sold 3,667 shares of KPTI for $2,647 on Sep 04 ’24. The President and CEO now owns 1,139,214 shares after completing the transaction at $0.72 per share. On Sep 04 ’24, another insider, Mason Michael, who serves as the EVP, CFO & Treasurer of the company, sold 7,050 shares for $0.72 each. As a result, the insider received 5,089 and left with 391,054 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 87029432 and an Enterprise Value of 209022560. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.60. Its current Enterprise Value per Revenue stands at 1.435 whereas that against EBITDA is -1.6.
Stock Price History:
Over the past 52 weeks, KPTI has reached a high of $1.95, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -16.78%, while the 200-Day Moving Average is calculated to be -31.64%.
Shares Statistics:
The stock has traded on average 992.32K shares per day over the past 3-months and 443710 shares per day over the last 10 days, according to various share statistics. A total of 114.92M shares are outstanding, with a floating share count of 113.93M. Insiders hold about 8.63% of the company’s shares, while institutions hold 54.20% stake in the company. Shares short for KPTI as of 1724976000 were 18515873 with a Short Ratio of 18.66, compared to 1722384000 on 18373169. Therefore, it implies a Short% of Shares Outstanding of 18515873 and a Short% of Float of 15.14.
